Published in
Elsevier, Kidney International Reports, 4(2), p. 654-664
DOI: 10.1016/j.ekir.2017.02.019
Links
Tools
Efficacy and Safety of Sparsentan Compared With Irbesartan in Patients With Primary Focal Segmental Glomerulosclerosis: Randomized, Controlled Trial Design (DUET)
Journal article published in 2017 by
Radko Komers,
Debbie S. Gipson 
,
Peter Nelson,
Sharon Adler,
Tarak Srivastava,
Vimal K. Derebail,
Kevin E. Meyers,
Pablo Pergola,
Meghan E. MacNally,
Jennifer L. Hunt,
Alvin Shih,
Howard Trachtman
,
Peter Nelson,
Sharon Adler,
Tarak Srivastava,
Vimal K. Derebail,
Kevin E. Meyers,
Pablo Pergola,
Meghan E. MacNally,
Jennifer L. Hunt,
Alvin Shih,
Howard Trachtman
This paper is made freely available by the publisher.
Full text: Download
Postprint:
archiving forbidden
Published version:
archiving forbidden
Data provided by 